T. Bois

Long-Term, Open-Label Extension Study of the Efficacy and Safety of Epicutaneous Immunotherapy for Peanut Allergy in Children: PEOPLE 3-Year Results.

William H. Yang, H. Sampson, V. Mahler, 2020, The Journal of allergy and clinical immunology.

Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.

A. Burks, H. Sampson, B. Vickery, 2023, The New England journal of medicine.

Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results.

William H. Yang, N. Rupp, H. Sampson, 2021, The journal of allergy and clinical immunology. In practice.

Immune response evolution in peanut epicutaneous immunotherapy for peanut‐allergic children

W. Carr, D. Fleischer, M. Greenhawt, 2023, Allergy.